Nirma Group

Nuvoco Vistas Q1 profit surges to Rs 133 cr on trade, premium sales

Nuvoco Vistas posts multi-fold profit growth to Rs 133 cr in Q1 FY26 on low base, premium products and trade sales; eyes Western expansion after Vadraj deal

Nuvoco Vistas Corp Q4FY25 results: Net profit jumps 65%, revenue up 3.7%

The profit stood at ₹165.54 crore, driven by a 40 per cent share of premium products in the company's trade sales

Nuvoco-Vadraj deal via insolvency route valued at up to Rs 3,000 crore

On Monday, Nuvoco announced it had emerged as the successful applicant for Vadraj Cement in the corporate insolvency resolution process but did not disclose the deal value

Nirma Group's Nuvoco Vistas Corp to buy Vadraj Cement via NCLT route

Acquisition to increase the fifth-largest cement maker's capacity by 20 per cent

Nirma's open offer to buy more stake in Glenmark Life to start on Feb 15

Nirma Ltd will kick off a Rs 1,343.05-crore open offer next week to acquire an additional 17.33 per cent stake from public shareholders of Glenmark Life Sciences Ltd, according to a regulatory filing. The development follows Nirma's deal to acquire 75 per cent stake in Glenmark Life Sciences for Rs 5,651.5 crore agreed in September last year. The open offer is being made to the public shareholders to acquire up to 2.13 crore equity shares representing 17.33 per cent of the voting share capital at an offer price of Rs 631.20 per share aggregating to a total consideration of up to Rs 1,343.05 crore, said the letter of offer by Nirma shared on BSE by Glenmark Life Sciences. The offer shares include the entire public shareholding in the target company (over 2.1 crore shares) and 2.63 lakh vested ESOPs, it added. The opening date (commencement of the tendering period) for the open offer has been fixed on February 15, 2024 and will close on February 29, 2024, as per the letter of offer,

Nirma Ltd to raise upto Rs 3,500 cr for business growth, acquisition

The company has proposed to acquire Glenmark Life Sciences Ltd (GLSL) to diversify its business. The acquisition is likely to be funded largely through debt

Nirma looks to raise up to Rs 7,000 crore to fund buys and expansion

The unlisted company posted revenues to the tune of Rs 11,403 crore in fiscal 2023

Nirma, 3 private equity firms in race to buy Glenmark Life Sciences

Glenmark owns 82.8 per cent stake in the company which closed at a total market valuation of Rs 6,361 crore on Tuesday with its shares closing at Rs 519 a share on Tuesday

Nuvoco Vistas hits new high, trades above issue price for first time

The stock was trading above its issue price of Rs 570 for the first time since listing

Franklin Templeton schemes receive pre-payment from Nirma's cement arm

The two debt papers were to mature in September 2020 and September 2021, respectively

Low valuations don't make Emami a cool bet; investors advised caution

In the past 1-2 years, Emami has seen muted volume off-take, thanks to higher dependence on wholesale distribution and competitive pressures

Will fund Lafarge deal through equity and target level financing: Nirma

Says deal is in line with strategy to pursue organic and inorganic expansion in diversified verticals